Sponsored Symposia Overview
Tuesday 19 October | 13:00-14:00 Mozambique time
Merck
Gender Equity in Health: Female genital schistosomiasis – a major challenge for Women’s Health in Sub-Saharan Africa
Medicines for Malaria Venture (MMV)
Main post-approval and real-life studies conducted and ongoing in parallel with the launch and scale-up of Pyramax in Africa
Instituto de Salud Carlos III (ISCIII)
Fostering a stronger collaboration in Personalised medicine: The EU-Africa PerMed project
European Global Health Research Institutes Network (EGHRIN)
Equal Voices: Addressing Inequities in Global Health Research Participation
Wednesday 20 October | 13:00-14:00 Mozambique time
Amsterdam Institute for Global Health and Development (PAVIA) & Karolinska Institutet (PROFORMA)
Equity in safety: improving pharmacovigilance of drugs and vaccines in Africa
Barcelona Institute for Global Health (ISGlobal)
Advances in Intermittent Preventive Treatment of malaria in infants (IPTi) for improved and equitable health for children under 2 in sub-Saharan Africa
Drugs for Neglected Diseases initiative (DNDi)
Addressing equity challenges in health for neglected populations
Deutsche Stiftung Weltbevölkerung (DSW)
Advocacy challenges and opportunities for stepping up support for poverty-related and neglected disease R&D after COVID-19
The European & Developing Countries Clinical Trials Partnership
The EDCTP2 programme is supported under Horizon 2020, the European Union’s Framework Programme for Research & Innovation.
© Copyright 2021 EDCTP